Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins

被引：54

作者：

Boeckx, Carolien ^{[1
]}

de Beeck, Ken Op ^{[1
,2
,3
]}

Wouters, An ^{[1
]}

Deschoolmeester, Vanessa ^{[1
]}

Limame, Ridha ^{[1
]}

Zwaenepoel, Karen ^{[4
]}

Specenier, Pol ^{[1
,5
]}

Pauwels, Patrick ^{[1
,4
]}

Vermorken, Jan B. ^{[1
,5
]}

Peeters, Marc ^{[1
,5
]}

Van Camp, Guy ^{[2
,3
]}

Baay, Marc ^{[1
]}

Lardon, Filip ^{[1
]}

机构：

[1] Univ Antwerp, CORE Antwerp, Lab Canc Res & Clin Oncol, Antwerp, Belgium

[2] Univ Antwerp, Ctr Med Genet, Dept Biomed Sci, Antwerp, Belgium

[3] Univ Antwerp Hosp, Antwerp, Belgium

[4] Univ Antwerp Hosp, Dept Pathol, Antwerp, Belgium

[5] Univ Antwerp Hosp, Dept Med Oncol, Antwerp, Belgium

来源：

CANCER LETTERS | 2014年 / 354卷 / 02期

关键词：

Head and neck squamous cell carcinoma; Anti-EGFR therapy; Cetuximab resistance; Dual-specificity phosphatase 5 and 6; Aurora kinase B; Nano Pro 1000; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; APIGENIN INDUCES APOPTOSIS; NECK-CANCER; COLORECTAL-CANCER; PANCREATIC-CANCER; MESENCHYMAL TRANSITION; AURORA KINASES; MONOCLONAL-ANTIBODY;

D O I：

10.1016/j.canlet.2014.08.039

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Unraveling the underlying mechanisms of cetuximab resistance in head and neck squamous cell carcinoma (HNSCC) is of major importance as many tumors remain non-responsive or become resistant. Our microarray results suggest that "resistant" cells still exhibit RAS-MAPK pathway signaling contributing to drug resistance, as witnessed by low expression of DUSP5 and DUSP6, negative regulators of ERK1/2, and increased expression of AURKB, a key regulator of mitosis. Therefore, interrupting the RAS-MAPK pathway by an ERK1/2 inhibitor (apigenin) or an AURKB inhibitor (barasertib) might be a new strategy for overcoming cetuximab resistance in HNSCc. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：365 / 377

页数：13

共 50 条

[41] Overcoming de novo and acquired modes of cetuximab resistance by broad-spectrum receptor tyrosine kinase inhibitors
Singh, Bhuminder
Graves-Deal, Ramona
Bogatcheva, Galina
Coffey, Robert J.
CANCER RESEARCH, 2019, 79 (13)
[42] Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells
Lu, Yang
Shi, Chunmei
Qiu, Songbo
Fan, Zhen
ONCOTARGET, 2016, 7 (40) : 64766 - 64777
[43] Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
Mir, Suhail Ahmad
Hamid, Laraibah
Bader, Ghulam Nabi
Shoaib, Ambreen
Rahamathulla, Mohamed
Alshahrani, Mohammad Y.
Alam, Prawez
Shakeel, Faiyaz
MOLECULES, 2022, 27 (19):
[44] Role of genomics-based strategies in overcoming chemotherapeutic resistance
Kumar, MV
Shirley, R
Ma, YL
Lewis, RW
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (05) : 471 - 480
[45] Overcoming TRAIL resistance by dipyridamole: A new role for an old drug
Goda, Ahmed
Yoshida, Tatsushi
Horinaka, Mano
Yasuda, Takashi
Shiraishi, Takumi
Wakada, Miki
Sakai, Toshiyuki
CANCER RESEARCH, 2009, 69
[46] The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Dana, Maleki Parisa
Sadoughi, Fatemeh
Asemi, Zatollah
Yousefi, Bahman
CELLULAR & MOLECULAR BIOLOGY LETTERS, 2022, 27 (01)
[47] The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Parisa Maleki Dana
Fatemeh Sadoughi
Zatollah Asemi
Bahman Yousefi
Cellular & Molecular Biology Letters, 2022, 27
[48] Role of endothelial-specific growth-factors in efficacy of cetuximab in pts with head and neck squamous cell carcinoma (HNSCC).
Vladimirova, Liubov Yu
Frantsiyants, Elena Mikhaylovna
Engibaryan, Marina
Agieva, Aza
Pogorelova, Yulia A.
Abramova, Natalya A.
Pustovaya, Irina Viktorovna
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[49] Metabolic Imaging Using Hyperpolarized PyruvateLactate Exchange Assesses Response or Resistance to the EGFR Inhibitor Cetuximab in Patient-Derived HNSCC Xenografts
Mignion, Lionel
Acciardo, Stefania
Gourgue, Florian
Joudiou, Nicolas
Caignet, Xavier
Goebbels, Rose-Marie
Corbet, Cyril
Feron, Olivier
Bouzin, Caroline
Cani, Patrice D.
Machiels, Jean-Pascal
Schmitz, Sandra
Jordan, Benedicte F.
CLINICAL CANCER RESEARCH, 2020, 26 (08) : 1932 - 1943
[50] THE ROLE OF PROTEINS IN RELATION TO RESISTANCE TO INFECTION
CANNON, PR
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1950, 116 (879) : 451 - 453

← 1 2 3 4 5 →